Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of lisdexamfetamine and methylphenidate in adult ADHD
IRCT20221018056238N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of lisdexamfetamine and methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Tehran University of Medical Sciences. Started Oct 2022; status: completed.
02
Drugs
lisdexamfetaminemethylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT20221018056238N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221018056238N1.